Boston Scientific (BSX) Tops Q1 EPS by 4c; Boosts FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
Go back to Boston Scientific (BSX) Tops Q1 EPS by 4c; Boosts FY16 Outlook
April 27, 2016 2:13 PM EDT
Needham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $22.00), saying Q1 marks and inflection point for growth and margins.
Matson commented, "BSX beat consensus 1Q16 revenue and EPS by a wide margin.... More
April 27, 2016 1:02 PM EDT
Evercore ISI analyst Vijay Kumar raised estimates and his price target on Boston Scientific (NYSE: BSX) to $23.50 (from $21.50) due to market multiple expansion. The firm maintained a Buy rating.
FY16 EPS was raised from $1.06 to $1.11 mainly due to higher organic revenue growth (mainly from... More
April 27, 2016 9:53 AM EDT
Boston Scientific (NYSE: BSX) is strong out of the gate following better-than-expected earnings and a raised outlook. Shares last traded up 8.9%.
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the... More
